John Hayslip
Chief Tech/Sci/R&D Officer chez VERASTEM, INC.
Profil
John Hayslip is currently the Chief Medical Officer at Verastem, Inc. He previously worked as the Director-Clinical Research & Data Management at The Markey Cancer Center Foundation and as the Vice President-Clinical Development at Nektar Therapeutics.
From 2022 to 2024, he served as the Chief Medical Officer at I-Mab.
Dr. Hayslip holds a graduate degree from the Medical University of South Carolina and a doctorate degree from Northeast Ohio Medical University.
Postes actifs de John Hayslip
| Sociétés | Poste | Début |
|---|---|---|
| VERASTEM, INC. | Chief Tech/Sci/R&D Officer | 18/04/2024 |
Anciens postes connus de John Hayslip
| Sociétés | Poste | Fin |
|---|---|---|
| I-MAB | Chief Tech/Sci/R&D Officer | 15/04/2024 |
| The Markey Cancer Center Foundation | Corporate Officer/Principal | - |
| NEKTAR THERAPEUTICS | Chief Tech/Sci/R&D Officer | - |
Formation de John Hayslip
| Medical University of South Carolina | Graduate Degree |
| Northeast Ohio Medical University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| NEKTAR THERAPEUTICS | Health Technology |
| VERASTEM, INC. | Health Technology |
| I-MAB | Health Technology |
| Entreprise privées | 1 |
|---|---|
| The Markey Cancer Center Foundation |
